Evidence map›Paper›PMID 39767172›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Multiple Red Flags of Cardiac Amyloidosis in a Single Patient: Clinical Manifestations of an Underdiagnosed Disease.

Emil Julian Dąbrowski, Wiktoria Urszula Kozłowska, Patrycja Oliwia Lipska, Urszula Matys, Szymon Pogorzelski, Marcin Kożuch, Sławomir Dobrzycki

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emil Julian DąbrowskiDepartment of Invasive Cardiology, Medical University of Białystok, 15-089 Białystok, Poland.ORCID 0000-0001-7598-1913
Wiktoria Urszula KozłowskaDepartment of Invasive Cardiology, Medical University of Białystok, 15-089 Białystok, Poland.
Patrycja Oliwia LipskaDepartment of Invasive Cardiology, Medical University of Białystok, 15-089 Białystok, Poland.
Urszula MatysDepartment of Invasive Cardiology, Medical University of Białystok, 15-089 Białystok, Poland.
Szymon PogorzelskiDepartment of Invasive Cardiology, Medical University of Białystok, 15-089 Białystok, Poland.
Marcin KożuchDepartment of Invasive Cardiology, Medical University of Białystok, 15-089 Białystok, Poland.ORCID 0000-0002-1430-7455
Sławomir DobrzyckiDepartment of Invasive Cardiology, Medical University of Białystok, 15-089 Białystok, Poland.

Funding

Medical University of Bialystok B.SUB.23.600Medical University of Bialystok B.SUB.24.181Medical University of Białystok B.SUB.24.535
6 · The paper itself

Abstract

Cardiac transthyretin amyloidosis is an underdiagnosed disorder with significant diagnostic difficulties due to its non-specific clinical manifestations. It is caused by the deposition of protein aggregates with an abnormal tertiary structure in the extracellular matrix. Their accumulation leads to the development of hypertrophic and restrictive cardiomyopathy and, at a later stage, heart failure with preserved ejection fraction syndrome. Depending on the pathogenesis, there are different types of the disease-hereditary and age-related wild-type transthyretin amyloidosis. We present the case of an 85-year-old woman who was referred to the department with a two-month history of exertional dyspnea in New York Heart Association functional class II. After reviewing the initial findings, several red flags for cardiac amyloidosis (CA) were identified. Following the diagnostic algorithm, scintigraphy was performed and showed significant radioisotope accumulation in the myocardium, confirming the suspected disease. In this manuscript, we present the current recommendations and diagnostic pathway, discussing in detail both available and emerging treatment options. As early diagnosis is essential to prevent the development of serious complications, we would like to highlight the pitfalls in diagnosing CA and emphasize the need to be aware of its variable clinical presentation and red flags.

Indexed as

amyloidosiscardiomyopathyheart failurescintigraphy

Identifiers

PMID39767172
PMCPMC11674418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.